Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Elesclomol> ?p ?o }
Showing triples 1 to 92 of
92
with 100 triples per page.
- Elesclomol abstract "Elesclomol (INN, codenamed STA-4783) is a drug that triggers apoptosis (programmed cell death) in cancer cells. It is being developed by Synta Pharmaceuticals and GlaxoSmithKline as a chemotherapy adjuvant, and has received both fast track and orphan drug status from the U.S. Food and Drug Administration for the treatment of metastatic melanoma. Synta Pharmaceuticals announced on February 26, 2009 the suspension of all clinical trials involving Elesclomol due to safety concerns. In March 2010, Synta announced that the FDA had approved resuming clinical development of elesclomol, and that they expected to initiate one or more clinical trials for elesclomol in the second half of the year.In a small, randomized phase II study, elesclomol was shown to significantly increase progression-free survival in people with metastatic melanoma when given in addition to paclitaxel (Taxol).".
- Elesclomol atcPrefix "none".
- Elesclomol casNumber "488832-69-5".
- Elesclomol chEBI "79369".
- Elesclomol fdaUniiCode "6UK191M53P".
- Elesclomol iupacName "N′1,N′3-dimethyl-N′1,N′3- bis(phenylcarbonothioyl)propanedihydrazide".
- Elesclomol pubchem "300471".
- Elesclomol thumbnail Elesclomol.svg?width=300.
- Elesclomol wikiPageID "20362616".
- Elesclomol wikiPageLength "6140".
- Elesclomol wikiPageOutDegree "23".
- Elesclomol wikiPageRevisionID "680747119".
- Elesclomol wikiPageWikiLink Adjuvant.
- Elesclomol wikiPageWikiLink Apoptosis.
- Elesclomol wikiPageWikiLink Cancer.
- Elesclomol wikiPageWikiLink Category:Chemotherapeutic_adjuvants.
- Elesclomol wikiPageWikiLink Category:Hydrazides.
- Elesclomol wikiPageWikiLink Category:Orphan_drugs.
- Elesclomol wikiPageWikiLink Clinical_trial.
- Elesclomol wikiPageWikiLink FDA_Fast_Track_Development_Program.
- Elesclomol wikiPageWikiLink Food_and_Drug_Administration.
- Elesclomol wikiPageWikiLink GlaxoSmithKline.
- Elesclomol wikiPageWikiLink International_nonproprietary_name.
- Elesclomol wikiPageWikiLink Melanoma.
- Elesclomol wikiPageWikiLink Metastasis.
- Elesclomol wikiPageWikiLink Orphan_drug.
- Elesclomol wikiPageWikiLink Oxidative_stress.
- Elesclomol wikiPageWikiLink Paclitaxel.
- Elesclomol wikiPageWikiLink Progression-free_survival.
- Elesclomol wikiPageWikiLink Randomized_controlled_trial.
- Elesclomol wikiPageWikiLink Reactive_oxygen_species.
- Elesclomol wikiPageWikiLink Screening_(medicine).
- Elesclomol wikiPageWikiLink Statistical_significance.
- Elesclomol wikiPageWikiLink Synta_Pharmaceuticals.
- Elesclomol wikiPageWikiLink Taras_Shevchenko_National_University_of_Kyiv.
- Elesclomol wikiPageWikiLinkText "Elesclomol".
- Elesclomol wikiPageWikiLinkText "elesclomol".
- Elesclomol alt "Skeletal formula".
- Elesclomol alt "Space-filling model".
- Elesclomol atcPrefix "none".
- Elesclomol c "19".
- Elesclomol casNumber "488832".
- Elesclomol chebi "79369".
- Elesclomol chembl "1972860".
- Elesclomol chemspiderid "265501".
- Elesclomol h "20".
- Elesclomol image "Elesclomol-3D-spacefill.png".
- Elesclomol iupacName "N′1,N′3-dimethyl-N′1,N′3- bispropanedihydrazide".
- Elesclomol molecularWeight "400.518".
- Elesclomol n "4".
- Elesclomol o "2".
- Elesclomol pubchem "300471".
- Elesclomol s "2".
- Elesclomol stdinchi "1".
- Elesclomol stdinchikey "BKJIXTWSNXCKJH-UHFFFAOYSA-N".
- Elesclomol unii "6".
- Elesclomol verifiedfields "changed".
- Elesclomol verifiedrevid "446146469".
- Elesclomol watchedfields "changed".
- Elesclomol width "250".
- Elesclomol wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Elesclomol wikiPageUsesTemplate Template:Cascite.
- Elesclomol wikiPageUsesTemplate Template:Chemotherapeutic_agents.
- Elesclomol wikiPageUsesTemplate Template:Chemspidercite.
- Elesclomol wikiPageUsesTemplate Template:Drugbankcite.
- Elesclomol wikiPageUsesTemplate Template:Drugbox.
- Elesclomol wikiPageUsesTemplate Template:Ebicite.
- Elesclomol wikiPageUsesTemplate Template:Fdacite.
- Elesclomol wikiPageUsesTemplate Template:Reflist.
- Elesclomol wikiPageUsesTemplate Template:Stdinchicite.
- Elesclomol subject Category:Chemotherapeutic_adjuvants.
- Elesclomol subject Category:Hydrazides.
- Elesclomol subject Category:Orphan_drugs.
- Elesclomol hypernym Drug.
- Elesclomol type ChemicalSubstance.
- Elesclomol type Drug.
- Elesclomol type Chemical.
- Elesclomol type Drug.
- Elesclomol type Hydrazide.
- Elesclomol type ChemicalObject.
- Elesclomol type Thing.
- Elesclomol type Q8386.
- Elesclomol comment "Elesclomol (INN, codenamed STA-4783) is a drug that triggers apoptosis (programmed cell death) in cancer cells. It is being developed by Synta Pharmaceuticals and GlaxoSmithKline as a chemotherapy adjuvant, and has received both fast track and orphan drug status from the U.S. Food and Drug Administration for the treatment of metastatic melanoma. Synta Pharmaceuticals announced on February 26, 2009 the suspension of all clinical trials involving Elesclomol due to safety concerns.".
- Elesclomol label "Elesclomol".
- Elesclomol sameAs Q5359460.
- Elesclomol sameAs m.04zxdbn.
- Elesclomol sameAs Elesklomol.
- Elesclomol sameAs Elesklomol.
- Elesclomol sameAs Q5359460.
- Elesclomol wasDerivedFrom Elesclomol?oldid=680747119.
- Elesclomol depiction Elesclomol.svg.
- Elesclomol isPrimaryTopicOf Elesclomol.